Articles with public access mandates - Caroline MirandaLearn more
Not available anywhere: 1
Gap junction coupling and islet delta-cell function in health and disease
C Miranda, M Begum, E Vergari, LJB Briant
Peptides 147, 170704, 2022
Mandates: Wellcome Trust
Available somewhere: 12
δ‐cells and β‐cells are electrically coupled and regulate α‐cell activity via somatostatin
LJB Briant, TM Reinbothe, I Spiliotis, C Miranda, B Rodriguez, P Rorsman
The Journal of physiology 596 (2), 197-215, 2018
Mandates: Swedish Research Council, British Heart Foundation, UK Engineering and …
Sense-antisense lncRNA pair encoded by locus 6p22. 3 determines neuroblastoma susceptibility via the USP36-CHD7-SOX9 regulatory axis
T Mondal, PK Juvvuna, A Kirkeby, S Mitra, ST Kosalai, L Traxler, ...
Cancer Cell 33 (3), 417-434. e7, 2018
Mandates: Knut and Alice Wallenberg Foundation, Swedish Research Council
GLP‐1 suppresses glucagon secretion in human pancreatic alpha‐cells by inhibition of P/Q‐type Ca2+ channels
R Ramracheya, C Chapman, M Chibalina, H Dou, C Miranda, A González, ...
Physiological reports 6 (17), e13852, 2018
Mandates: Knut and Alice Wallenberg Foundation, Swedish Research Council, Diabetes UK …
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
A Kim, JG Knudsen, JC Madara, A Benrick, TG Hill, LA Kadir, JA Kellard, ...
Elife 10, e72919, 2021
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
MCPH1 maintains long‐term epigenetic silencing of ANGPT2 in chronic lymphocytic leukemia
PK Kopparapu, C Miranda, L Fogelstrand, K Mishra, PO Andersson, ...
The FEBS journal 282 (10), 1939-1952, 2015
Mandates: Swedish Research Council
GLP-1 metabolite GLP-1 (9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
NR Gandasi, R Gao, L Kothegala, A Pearce, C Santos, S Acreman, ...
Diabetologia 67 (3), 528-546, 2024
Mandates: Swiss National Science Foundation, Knut and Alice Wallenberg Foundation …
Somatostatin containing δ-cell number is reduced in type-2 diabetes
L Kothegala, C Miranda, M Singh, JP Krieger, NR Gandasi
International Journal of Molecular Sciences 24 (4), 3449, 2023
Mandates: Department of Biotechnology, India, Juvenile Diabetes Research Foundation
GLP-1 (9-36) mediates the glucagonostatic effect of GLP-1 by promiscuous activation of the glucagon receptor
C Guida, C Miranda, IW Asterholm, D Basco, A Benrick, B Chanclon, ...
bioRxiv, 785667, 2020
Mandates: Swiss National Science Foundation, Knut and Alice Wallenberg Foundation …
Lipophilicity predicts the ability of nonsulphonylurea drugs to block pancreatic beta‐cell KATP channels and stimulate insulin secretion; statins as a test case
J Real, C Miranda, CS Olofsson, PA Smith
Endocrinology, diabetes & metabolism 1 (2), e00017, 2018
Mandates: Swedish Research Council
Hindbrain insulin controls feeding behavior
K Eerola, F Longo, TM Reinbothe, JE Richard, OT Shevchouk, ...
Molecular Metabolism 66, 101614, 2022
Mandates: Knut and Alice Wallenberg Foundation, Swedish Research Council
AVP-induced counter-regulatory glucagon is diminished in type 1 diabetes
A Kim, JG Knudsen, JC Madara, A Benrick, T Hill, LA Kadir, JA Kellard, ...
BioRxiv, 2020
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Promiscuous receptor activation mediates glucagonostatic effects of GLP-1 (9-36) and GLP-1 (7-36)
C Guida, C Miranda, IW Asterholm, D Basco, A Benrick, B Chanclon, ...
bioRxiv, 785667, 2019
Mandates: Swiss National Science Foundation, Knut and Alice Wallenberg Foundation …
Publication and funding information is determined automatically by a computer program